NCT04378920View on ClinicalTrials.gov

A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

August 24, 2021

Study Completion Date

August 24, 2021

Conditions
COVID19, Sepsis or Other CausesAcute Respiratory Distress Syndrome
Interventions
DRUG

LEAF-4L6715

LEAF-4L6715

Trial Locations (2)

67000

Hôpitaux Universitaires de Strasbourg, Strasbourg

67033

Institut de cancérologie Strasbourg Europe, Strasbourg

All Listed Sponsors
collaborator

LEAF4Life, Inc.

INDUSTRY

lead

Institut de cancérologie Strasbourg Europe

OTHER

NCT04378920 - A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes | Biotech Hunter | Biotech Hunter